Compositions and methods for lipid production
US-2018201943-A1 · Jul 19, 2018 · US
US10920233B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10920233-B2 |
| Application number | US-201715855237-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 27, 2017 |
| Priority date | May 3, 2013 |
| Publication date | Feb 16, 2021 |
| Grant date | Feb 16, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.
Opening claim text (preview).
What is claimed is: 1. A method of producing a lipid, lipid precursor, or oleochemi cal comprising: 1) culturing a genetically modified Yarrowia lipolytica yeast cell in a growth medium; and 2) isolating said lipid, lipid precursor, or oleochemical; wherein the dry weight of said genetically modified yeast cell comprises greater than 60% wt/wt lipids, lipid precursors, and oleochemicals; wherein said genetically modified yeast cell comprises (i) a recombinant acvl- CoA:diacvlglvcerol acvltransferase 1 (DGA1) gene and a genetically modified lipid synthesis regulator (MGA2) gene, wherein said genetically modified MGA2 gene increases lipid production compared to a non-genetically modified MGA2 control; or (ii) a recombinant acvl-CoA:diacvlglvcerol acvltransferase 2 (DGA2) gene and a genetically modified lipid synthesis regulator (MGA2) gene, wherein said genetically modified MGA2 gene increases lipid production compared to a non-genetically modified MGA2 control; and wherein said lipid, lipid precursor, or oleochemical is not a sterol. 2. The method of claim 1 , wherein said growth medium comprises a majority carbon source selected from the group consisting of glucose, glycerol, xylose, fructose, mannose, ribose, sucrose, and lignocellulosic biomass. 3. The method of claim 1 , wherein said growth medium comprises lignocellulosic biomass as the majority carbon source. 4. The method of claim 1 , wherein said growth medium comprises cobalt, iron, magnesium, potassium, zinc, nickel, molybdenum, manganese, copper, or boron. 5. The method of claim 1 , wherein said growth medium comprises 5.77×10 −5 M to 1.73x10 −4 M cobalt, 0.001 M to 0.003 M magnesium, 4.52×10 −5 M to 1.35x10 −4 M potassium, 4.05×10 5 M to 1.22x10 −4 zinc, 3.55×10 −5 M to 1.06×10 −4 manganese, 9.07×10 −5 M to 2.91x10 −4 boron, 3.76×10 −5 M to 1.10×10 −4 molybdenum, 2.28×10 −5 M to 6.84×10 −5 nickel, 3.60×10 −5 M to 1.08x10 −4 iron, or 4.70×10 −5 M to 1.41x10 −4 copper. 6. The method of claim 1 , wherein said genetically modified MGA2 gene comprises at least one nucleotide modification. 7. The method of claim 1 , wherein said genetically modified MGA2 gene comprises SEQ ID NO: 51. 8. The method of claim 1 , wherein said genetically modified yeast cell further comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MEFI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene or a recombinant AMP Deaminase (AMPD) gene. 9. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MEFI) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 10. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 11. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD) gene. 12. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD) gene.
Fungi {; Processes using fungi} · CPC title
Fungi isolates · CPC title
Fatty acids · CPC title
Lyases (4.) · CPC title
obtained from glyceride producing microorganisms, e.g. single cell oil · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.